在初级阿尔多斯特隆主义中使用芬瑞龙的现实结果
Thomas Uslar1,2, Benjamín Sanfuentes1, Iván Muñoz3
1Department of Endocrinology, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.
European journal of endocrinology
|May 16, 2025
概括
芬龙是一种新的矿物质皮质类受体对抗剂 (MRA),与eplerenone相比,在原发性阿尔多斯特隆症 (PA) 患者的有效性降低. 这项现实研究发现血压降低和生化反应降低,强调需要进一步研究.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 矿物质皮质类受体抗剂 (MRAs) 是对原发性阿尔多斯铁症 (PA) 的标准治疗方法.
- 目前的MRA存在一些局限性,包括副作用和可变的强度.
- 菲内伦是一种具有潜力的新型MRA,但其在PA中的疗效尚未得到充分证实.
研究的目的:
- 为了评估先前用eplerenone治疗的PA患者中的finerenone的实际有效性.
- 在PA中比较eplerenone和finerenone治疗之间的临床和生化结果.
主要方法:
- 对PA患者进行了回顾性,现实世界的研究,由于药物短缺,他们从eplerenone转换为finerenone.
- 对血压控制,抗高血压药物剂量和生化反应 (包括直接宁度) 的分析.
主要成果:
- 在转换为finerenone期间,血压和抗高血压剂量保持稳定.
- 观察到患者达到正常血压的比例显著下降 (P = .004).
- 完整的生化反应率被显著降低与finerenone (P = .008),由较低的直接宁度表明.
结论:
- 与eplerenone相比,在PA患者的费内伦治疗导致生物化学反应降低.
- 观察到直接宁度的减少可能对心血管风险有影响.
- 需要进一步的研究,以了解finerenone的长期结果和在PA管理中的最佳使用.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
354
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
354
01:25Antihypertensive Drugs: Direct Renin Inhibitors
466
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
466
01:22Heart Failure Drugs: Diuretics
309
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
309
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
430
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
430
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
424
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
424